Krystal Biotech Inc (KRYS) — Cash Flow Reinvestment Rate
Krystal Biotech Inc (KRYS) has a Cash Flow Reinvestment Rate of 0.79x as of March 2026, reinvesting $63.58 Million (capex $7.15 Million plus investments $-56.44 Million) from operating cash flow of $80.38 Million. Check Krystal Biotech Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Krystal Biotech Inc Cash Flow Reinvestment Rate (2024–2025)
Historical reinvestment intensity for Krystal Biotech Inc across 2 annual periods. Explore Krystal Biotech Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Krystal Biotech Inc (2024–2025)
Year-by-year capital reinvestment analysis for Krystal Biotech Inc. For live market cap and broader valuation context, see KRYS stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.29x | $58.85 Million | $200.87 Million | $11.95 Million | ▼ -78.4% |
| 2024 | 1.36x | $167.68 Million | $123.42 Million | $4.24 Million | — |